Synergy between next generation EGFR tyrosine kinase inhibitors and miR-34a in the inhibition of non-small cell lung cancer
Keywords: MicroRNA; miR-34a; Erlotinib; Afatinib; Osimertinib; Rociletinib; EGFR:; epidermal growth factor receptor; TKI:; tyrosine kinase inhibitor; miRNA:; microRNA; DRI:; dose reduction index; CI:; combination index; NSCLC:; non-small cell lung cancer;